245 related articles for article (PubMed ID: 17475787)
1. Constitutive Ret activity in knock-in multiple endocrine neoplasia type B mice induces profound elevation of brain dopamine concentration via enhanced synthesis and increases the number of TH-positive cells in the substantia nigra.
Mijatovic J; Airavaara M; Planken A; Auvinen P; Raasmaja A; Piepponen TP; Costantini F; Ahtee L; Saarma M
J Neurosci; 2007 May; 27(18):4799-809. PubMed ID: 17475787
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine.
Mijatovic J; Patrikainen O; Yavich L; Airavaara M; Ahtee L; Saarma M; Piepponen TP
J Neurochem; 2008 Jun; 105(5):1716-25. PubMed ID: 18248620
[TBL] [Abstract][Full Text] [Related]
3. Constitutive Ret signaling is protective for dopaminergic cell bodies but not for axonal terminals.
Mijatovic J; Piltonen M; Alberton P; Männistö PT; Saarma M; Piepponen TP
Neurobiol Aging; 2011 Aug; 32(8):1486-94. PubMed ID: 19767128
[TBL] [Abstract][Full Text] [Related]
4. Constitutive Ret signaling leads to long-lasting expression of amphetamine-induced place conditioning via elevation of mesolimbic dopamine.
Kopra J; Villarta-Aguilera M; Savolainen M; Weingerl S; Myöhänen TT; Rannanpää S; Salvatore MF; Andressoo JO; Piepponen TP
Neuropharmacology; 2018 Jan; 128():221-230. PubMed ID: 29031851
[TBL] [Abstract][Full Text] [Related]
5. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M
Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446
[TBL] [Abstract][Full Text] [Related]
6. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
Sarabi A; Hoffer BJ; Olson L; Morales M
J Comp Neurol; 2001 Dec; 441(2):106-17. PubMed ID: 11745638
[TBL] [Abstract][Full Text] [Related]
7. Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.
Smith AD; Antion M; Zigmond MJ; Austin MC
Brain Res Mol Brain Res; 2003 Oct; 117(2):129-38. PubMed ID: 14559146
[TBL] [Abstract][Full Text] [Related]
8. Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Bongarzone I; Vigano E; Alberti L; Borrello MG; Pasini B; Greco A; Mondellini P; Smith DP; Ponder BA; Romeo G; Pierotti MA
Oncogene; 1998 May; 16(18):2295-301. PubMed ID: 9620546
[TBL] [Abstract][Full Text] [Related]
9. RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice.
Jain S; Golden JP; Wozniak D; Pehek E; Johnson EM; Milbrandt J
J Neurosci; 2006 Oct; 26(43):11230-8. PubMed ID: 17065462
[TBL] [Abstract][Full Text] [Related]
10. Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation.
Iwashita T; Asai N; Murakami H; Matsuyama M; Takahashi M
Oncogene; 1996 Feb; 12(3):481-7. PubMed ID: 8637703
[TBL] [Abstract][Full Text] [Related]
11. Sympathoadrenal hyperplasia causes renal malformations in Ret(MEN2B)-transgenic mice.
Gestblom C; Sweetser DA; Doggett B; Kapur RP
Am J Pathol; 1999 Dec; 155(6):2167-79. PubMed ID: 10595945
[TBL] [Abstract][Full Text] [Related]
12. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
Hung HC; Lee EH
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
[TBL] [Abstract][Full Text] [Related]
13. RET(Men2B)-transgene produces sympathoadrenal tumors but does not prevent intestinal aganglionosis in gdnf-/- or gfr alpha-1(-/-) mice.
Rajan I; Gestblom C; Kapur RP
Pediatr Dev Pathol; 2001; 4(5):446-53. PubMed ID: 11779046
[TBL] [Abstract][Full Text] [Related]
14. ret receptor tyrosine kinase immunoreactivity is altered in glial cell line-derived neurotrophic factor-responsive neurons following lesions of the nigrostriatal and septohippocampal pathways.
Araujo DM; Hilt DC; Miller PJ; Wen D; Jiao S; Lapchak PA
Neuroscience; 1997 Sep; 80(1):9-16. PubMed ID: 9252216
[TBL] [Abstract][Full Text] [Related]
15. The role of Ret receptor tyrosine kinase in dopaminergic neuron development.
Li L; Su Y; Zhao C; Zhao H; Liu G; Wang J; Xu Q
Neuroscience; 2006 Oct; 142(2):391-400. PubMed ID: 16879925
[TBL] [Abstract][Full Text] [Related]
16. Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain.
Galleguillos D; Fuentealba JA; Gómez LM; Saver M; Gómez A; Nash K; Burger C; Gysling K; Andrés ME
J Neurochem; 2010 Aug; 114(4):1158-67. PubMed ID: 20533997
[TBL] [Abstract][Full Text] [Related]
17. Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells.
Barroso-Chinea P; Cruz-Muros I; Aymerich MS; Rodríguez-Díaz M; Afonso-Oramas D; Lanciego JL; González-Hernández T
Eur J Neurosci; 2005 Apr; 21(7):1815-27. PubMed ID: 15869477
[TBL] [Abstract][Full Text] [Related]
18. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease.
Walker DG; Beach TG; Xu R; Lile J; Beck KD; McGeer EG; McGeer PL
Brain Res; 1998 May; 792(2):207-17. PubMed ID: 9593897
[TBL] [Abstract][Full Text] [Related]
19. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
[TBL] [Abstract][Full Text] [Related]
20. Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area.
Adelbrecht C; Agid Y; Raisman-Vozari R
Brain Res Mol Brain Res; 1996 Dec; 43(1-2):291-300. PubMed ID: 9037545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
